Name: Latest research reports of Alembic Pharmaceuticals Ltd. authored by BOB Capital Markets Ltd. and published by - Trendlyne research reports.
Item: Alembic Pharmaceuticals Ltd.
Rating: 5
Author: BOB Capital Markets Ltd.

Alembic Pharmaceuticals Ltd.

NSE: APLLTD | BSE: 533573 | ISIN: INE901L01018 | Industry: Pharmaceuticals
| Mid-range Performer

917.9000 13.60 (1.50%)

NSE Oct 03, 2025 10:26 AM

29.60% Fall from 52W High

Volume: 14,639

Alembic Pharmaceuticals Ltd.

11 Feb 2022

917.90

1.50%

Alembic Pharma (BUY): US business weak but showing signs of stabilising

Buy: Alembic Pharmaceuticals Ltd.

Recommendation Target

BOB Capital Markets Ltd.

Q3 revenue dipped 3% YoY on a steep decline in US (-23%) and API (-8%) business, despite growth in India (+17%) and ROW (+13%)

Alembic Pharmaceuticals Ltd. is trading below all available SMAs